Royal Bank of Canada
ANGO icon

Royal Bank of Canada’s AngioDynamics ANGO Stock Holding History

Royal Bank of Canada’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$817K Sell
71,872
-38,125
-35% -$413K ﹤0.01% 3776
2025
Q4 		$1.41M Sell
109,997
-4,943
-4% -$61K ﹤0.01% 3388
2025
Q3 		$1.28M Sell
114,940
-3,362
-3% -$32.4K ﹤0.01% 3770
2025
Q2 		$1.17M Sell
118,302
-84,246
-42% -$825K ﹤0.01% 3753
2025
Q1 		$1.9M Sell
202,548
-79,277
-28% -$833K ﹤0.01% 2982
2024
Q4 		$2.58M Buy
281,825
+24,804
+10% +$182K ﹤0.01% 2836
2024
Q3 		$2M Sell
257,021
-3,350
-1% -$24.2K ﹤0.01% 3002
2024
Q2 		$1.58M Buy
260,371
+49,569
+24% +$306K ﹤0.01% 3082
2024
Q1 		$1.24M Buy
210,802
+58,357
+38% +$347K ﹤0.01% 3284
2023
Q4 		$1.2M Sell
152,445
-30,701
-17% -$213K ﹤0.01% 3522
2023
Q3 		$1.34M Buy
183,146
+34,722
+23% +$289K ﹤0.01% 3196
2023
Q2 		$1.55M Buy
148,424
+16,455
+12% +$158K ﹤0.01% 3034
2023
Q1 		$1.36M Buy
131,969
+61,504
+87% +$787K ﹤0.01% 3108
2022
Q4 		$970K Buy
70,465
+14,674
+26% +$204K ﹤0.01% 3533
2022
Q3 		$1.14M Sell
55,791
-3,025
-5% -$66.4K ﹤0.01% 3336
2022
Q2 		$1.14M Sell
58,816
-6,907
-11% -$141K ﹤0.01% 3382
2022
Q1 		$1.42M Buy
65,723
+12,381
+23% +$281K ﹤0.01% 3355
2021
Q4 		$1.47M Sell
53,342
-17,824
-25% -$492K ﹤0.01% 3432
2021
Q3 		$1.84M Sell
71,166
-15,527
-18% -$415K ﹤0.01% 3135
2021
Q2 		$2.35M Sell
86,693
-25,129
-22% -$614K ﹤0.01% 2918
2021
Q1 		$2.62M Sell
111,822
-17,436
-13% -$352K ﹤0.01% 2782
2020
Q4 		$1.98M Sell
129,258
-1,752
-1% -$22.2K ﹤0.01% 2924
2020
Q3 		$1.58M Sell
131,010
-6,652
-5% -$63.1K ﹤0.01% 2892
2020
Q2 		$1.4M Sell
137,662
-3,204
-2% -$33K ﹤0.01% 2905
2020
Q1 		$1.47M Buy
140,866
+35,955
+34% +$451K ﹤0.01% 2718
2019
Q4 		$1.68M Sell
104,911
-15,938
-13% -$243K ﹤0.01% 3034
2019
Q3 		$2.23M Buy
120,849
+2,709
+2% +$53K ﹤0.01% 2666
2019
Q2 		$2.33M Sell
118,140
-2,022
-2% -$41.2K ﹤0.01% 2631
2019
Q1 		$2.75M Sell
120,162
-1,408
-1% -$30.6K ﹤0.01% 2458
2018
Q4 		$2.45M Buy
121,570
+1,005
+0.8% +$20.8K ﹤0.01% 2502
2018
Q3 		$2.62M Buy
120,565
+3,726
+3% +$82.8K ﹤0.01% 2637
2018
Q2 		$2.6M Sell
116,839
-9,600
-8% -$196K ﹤0.01% 2526
2018
Q1 		$2.18M Buy
126,439
+3,981
+3% +$66.4K ﹤0.01% 2619
2017
Q4 		$2.04M Buy
122,458
+6,196
+5% +$106K ﹤0.01% 2708
2017
Q3 		$1.99M Buy
116,262
+7,358
+7% +$124K ﹤0.01% 2664
2017
Q2 		$1.76M Buy
108,904
+22,999
+27% +$364K ﹤0.01% 2687
2017
Q1 		$1.49M Buy
85,905
+66,327
+339% +$1.11M ﹤0.01% 2766
2016
Q4 		$331K Buy
19,578
+1,204
+7% +$20.1K ﹤0.01% 4117
2016
Q3 		$322K Buy
18,374
+374
+2% +$6.07K ﹤0.01% 4077
2016
Q2 		$258K Buy
18,000
+100
+0.6% +$1.25K ﹤0.01% 4223
2016
Q1 		$220K Sell
17,900
-5,266
-23% -$58.2K ﹤0.01% 4298
2015
Q4 		$281K Sell
23,166
-15,168
-40% -$187K ﹤0.01% 4277
2015
Q3 		$505K Buy
38,334
+2,079
+6% +$31.4K ﹤0.01% 3491
2015
Q2 		$594K Sell
36,255
-2,268
-6% -$37.7K ﹤0.01% 3451
2015
Q1 		$685K Buy
38,523
+3,621
+10% +$67.3K ﹤0.01% 3216
2014
Q4 		$663K Sell
34,902
-8,110
-19% -$137K ﹤0.01% 3291
2014
Q3 		$590K Sell
43,012
-51
-0.1% -$728 ﹤0.01% 3305
2014
Q2 		$703K Buy
43,063
+2
+0% +$29 ﹤0.01% 3127
2014
Q1 		$679K Buy
43,061
+51
+0.1% +$831 ﹤0.01% 3102
2013
Q4 		$738K Sell
43,010
-5,100
-11% -$78.5K ﹤0.01% 3101
2013
Q3 		$635K Sell
48,110
-345
-0.7% -$4.07K ﹤0.01% 3179
2013
Q2 		$546K Buy
+48,455
New +$516K ﹤0.01% 3077

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.5M AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $100M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAM
Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

Royal Bank of Canada's ANGO Position: Q1 2026 in Review

Royal Bank of Canada reduced its AngioDynamics (ANGO) stake by 35% in Q1 2026, selling an estimated $413K and leaving 71,872 shares worth $817K. The position accounts for ﹤0.01% of the portfolio, ranked #3776.

Royal Bank of Canada first reported a position in ANGO in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.75M in Q1 2019. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • Royal Bank of Canada held 71,872 shares of AngioDynamics worth $817K as of Q1 2026.
  • Royal Bank of Canada sold 38,125 AngioDynamics shares in Q1 2026, an estimated $413K.
  • AngioDynamics made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #3776 holding.
  • Royal Bank of Canada first reported a position in AngioDynamics in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's AngioDynamics position peaked at $2.75M in Q1 2019.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.